The European Medicines Agency defines “off-label” the use of a medicine for an unapproved indication or in an unapproved age group, dosage, or route of administration. The majority of marketed medicines world‐wide, including those commonly used or which could...
SAVE THE DATE. RESTORE Advanced Therapies Science Meeting on 25th and 26th November 2019 in Berlin: the TEDDY Network submitted 5 Abstracts
On 25th and 26th November 2019, the RESTORE First Advanced Therapies Science Meeting will take place in Berlin. The conference will highlight the science behind Advanced Therapies with a jam-packed agenda featuring leaders in science and technology development. TEDDY...
SAVE THE DATE. “Shaping the Future of Paediatrics”, the Conference organized by Bambino Gesù Children’s Hospital in Rome on 2th-4th October 2019
On 2th-4th October 2019 Bambino Gesù Children’s Hospital in partnership with the International Society of Pediatric Innovation (iSPI) will organise the Conference “Shaping the Future of Paediatrics” at Centro Congressi Piazza di Spagna in Rome. The Conference will...
SAVE THE DATE. 28th ERTC Workshop “A New PARADIGM of Meaningful Patient Engagement in the Life Cycle of Medicines” 15th October 2019, Barcelona, Spain
EURORDIS – Rare Disease Europe will organise the 28th EURORDIS Round Table of Companies Workshop on 15 October 2019 at the Hospital Sant Pau Recinte Modernista in Barcelona, Spain. The workshop entitled “A new PARADIGM of Meaningful Patient Engagement in the Life...
TEDDY involvement in the ENCePP activities focused on the EU PAS Register review
The European Union electronic Register of Post-Authorisation Studies (EU PAS Register) is a collection of non-interventional post-authorisation studies (PAS) and was launched in 2010 by ENCePP (European Network of Centres for Pharmacoepidemiology and...
European Commission launches online public survey on HORIZON EUROPE
The Commission is preparing for the crucial phases of the implementation of Horizon Europe (HE), the next EU research and innovation programme (2021-2027) with a proposed budget of 100 billion. In view of an intensive co-design approach, the Commission has launched an...
Have a look at the EJP RD events and training activities
The European Joint Programme on Rare Diseases (EJPRD) is a Co-fund action aimed to create a comprehensive, sustainable system allowing virtuous circle between research, care and medical innovation. TEDDY Network participates as Partner in this project and all of its...
The Italian Medicines Agency AIFA withdraws the paediatric indication for domperidone-containing products
The Italian Medicines Agency AIFA has just released a safety communication about the use of medicines containing domperidone. Domperidone-containing medicines have been authorised nationally in individual Member States of the EU for the treatment of nausea and...
KIDS Bari participated in the OPBG Innovation Meeting on 28 March, 2019
On March 28, 2019 the usual appointment with the Innovation Meeting promoted by the Paediatric Hospital Bambino Gesù was held in Rome. For more than one year, the Paediatric Hospital Bambino Gesù has been dedicating space and attention to these meetings, aimed to...
EMA Consultation: Electronic product information for human medicines in the European Union – draft key principles
The European Medicines Agency (EMA) has launched a six-month public consultation on draft key principles for Electronic Product Information (ePI) for human medicines in the EU. A medicine’s product information is regulated, scientifically validated information that...